- Home
- TRX vs ASRT Comparison
TRX vs ASRT Comparison
Compare TRX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- ASRT
- Stock Information
- Founded
- TRX 1990
- ASRT 1995
- Country
- TRX Canada
- ASRT United States
- Employees
- TRX N/A
- ASRT N/A
- Industry
- TRX
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- TRX
- ASRT Health Care
- Exchange
- TRX Nasdaq
- ASRT Nasdaq
- Market Cap
- TRX 109.5M
- ASRT 91.3M
- IPO Year
- TRX N/A
- ASRT 1997
- Fundamental
- Price
- TRX $0.33
- ASRT $0.90
- Analyst Decision
- TRX Strong Buy
- ASRT Strong Buy
- Analyst Count
- TRX 2
- ASRT 4
- Target Price
- TRX $1.63
- ASRT $3.19
- AVG Volume (30 Days)
- TRX 474.3K
- ASRT 908.1K
- Earning Date
- TRX 01-13-2025
- ASRT 11-11-2024
- Dividend Yield
- TRX N/A
- ASRT N/A
- EPS Growth
- TRX N/A
- ASRT N/A
- EPS
- TRX N/A
- ASRT N/A
- Revenue
- TRX $41,158,000.00
- ASRT $125,763,000.00
- Revenue This Year
- TRX $68.64
- ASRT N/A
- Revenue Next Year
- TRX $32.59
- ASRT $1.84
- P/E Ratio
- TRX N/A
- ASRT N/A
- Revenue Growth
- TRX 7.41
- ASRT N/A
- 52 Week Low
- TRX $0.31
- ASRT $0.73
- 52 Week High
- TRX $0.49
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- TRX 34.00
- ASRT 43.20
- Support Level
- TRX $0.35
- ASRT $0.90
- Resistance Level
- TRX $0.36
- ASRT $1.04
- Average True Range (ATR)
- TRX 0.01
- ASRT 0.06
- MACD
- TRX -0.00
- ASRT -0.00
- Stochastic Oscillator
- TRX 3.00
- ASRT 14.84
About TRX TRX Gold Corporation
TRX Gold Corp, formerly Tanzanian Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, Kigosi project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.